These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37295865)

  • 1. Reply to "Does hydroxychloroquine work for chronic spontaneous urticaria?".
    Bernstein DI; Khan N; Epstein TG
    J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1983-1984. PubMed ID: 37295865
    [No Abstract]   [Full Text] [Related]  

  • 2. Does hydroxychloroquine work for chronic spontaneous urticaria?
    Kaplan AP
    J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1983. PubMed ID: 37295866
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness of Hydroxychloroquine and Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study.
    Khan N; Epstein TG; DuBuske I; Strobel M; Bernstein DI
    J Allergy Clin Immunol Pract; 2022 Dec; 10(12):3300-3305. PubMed ID: 36115542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria.
    Skander D; Allenova A; Maurer M; Kolkhir P
    Eur Ann Allergy Clin Immunol; 2021 Mar; 53(2):91-93. PubMed ID: 32496030
    [No Abstract]   [Full Text] [Related]  

  • 5. Does synthetic pharmacotherapy still have a place in treating chronic spontaneous urticaria?
    Thiede RM; Fazel M; MacDonald KM; Abraham I
    Expert Opin Pharmacother; 2022 Oct; 23(14):1563-1567. PubMed ID: 36173375
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation.
    Reeves GE; Boyle MJ; Bonfield J; Dobson P; Loewenthal M
    Intern Med J; 2004 Apr; 34(4):182-6. PubMed ID: 15086698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenebrutinib and BTK inhibition: Unveiling a new target for the treatment of chronic spontaneous urticaria.
    Carvallo A; Sánchez-Fernández S; Morales-Palacios MP
    Allergy; 2023 Feb; 78(2):603-605. PubMed ID: 36420759
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of the immunoglobulin/histamine complex in chronic spontaneous urticaria focusing on remission induction.
    Kim HS; Noh G
    Allergy; 2022 Sep; 77(9):2846-2848. PubMed ID: 35587440
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective IgE Deficiency Predicts Poor or No Response of Chronic Spontaneous Urticaria to Omalizumab.
    Picado C; Mascaró JJ; Vlagea A; Pascal M; Muñoz-Cano R; Bartra J
    J Investig Allergol Clin Immunol; 2022 Dec; 32(6):504-506. PubMed ID: 35225792
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxychloroquine as a steroid-sparing agent in an infant with chronic urticaria.
    Iweala OI; Copenhaver C; Wu EY; Moran TP
    Ann Allergy Asthma Immunol; 2018 Jan; 120(1):102-104. PubMed ID: 29157861
    [No Abstract]   [Full Text] [Related]  

  • 11. The Crucial Role of IgE as a Predictor of Treatment Response to Omalizumab in Chronic Spontaneous Urticaria.
    Maurer M; Kolkhir P; Moñino-Romero S; Metz M
    J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2390-2391. PubMed ID: 37364668
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxychloroquine in the treatment of anti-histamine refractory chronic spontaneous urticaria, randomized single-blinded placebo-controlled trial and an open label comparison study.
    Boonpiyathad T; Sangasapaviliya A
    Eur Ann Allergy Clin Immunol; 2017 Sep; 49(5):220-224. PubMed ID: 28884989
    [No Abstract]   [Full Text] [Related]  

  • 13. Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three-month prospective study.
    Ghazanfar MN; Bartko EA; Arildsen NS; Poulsen LK; Jensen BM; Enevold C; Holm JG; Woetmann A; Ødum N; Thomsen SF
    Clin Exp Allergy; 2022 May; 52(5):715-718. PubMed ID: 35278253
    [No Abstract]   [Full Text] [Related]  

  • 14. Unique basophil microRNA signature in chronic spontaneous urticaria patients who respond to omalizumab.
    Al-Shaikhly T; MacDonald JW; Bammler TK; Altman MC; Ayars AG; Petroni DH; Tilles SA; Henderson WR
    Clin Exp Allergy; 2021 Dec; 51(12):1648-1652. PubMed ID: 34519110
    [No Abstract]   [Full Text] [Related]  

  • 15. Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience.
    Akdaş E; Adışen E; Öztaş MO; Aksakal AB; İlter N; Gülekon A
    An Bras Dermatol; 2023; 98(2):240-242. PubMed ID: 36567165
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-IL-23 treatment with tildrakizumab can be effective in omalizumab-refractory chronic spontaneous urticaria: A case series.
    Bonnekoh H; Kiefer L; Buttgereit T; Kolkhir P; Lütke-Eversloh M; Scheffel J; Maurer M; Metz M
    J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2578-2580.e1. PubMed ID: 37244440
    [No Abstract]   [Full Text] [Related]  

  • 17. Drugs in Development for Chronic Spontaneous Urticaria.
    Nguyen W; Liu W; Yamauchi P
    J Drugs Dermatol; 2023 Apr; 22(4):393-397. PubMed ID: 37026883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Urticaria.
    Hsu JI; Hsu S
    Skinmed; 2022; 20(5):364-366. PubMed ID: 36314703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Urticaria.
    Hsu JI; Hsu S
    Skinmed; 2022; 20(4):364-366. PubMed ID: 36314621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Omalizumab in Patients with Chronic Spontaneous Urticaria and Its Association with Serum IgE Levels and Eosinophil Count.
    Tamer F; Gulru Erdogan F; Dincer Rota D; Yildirim D; Akpinar Kara Y
    Acta Dermatovenerol Croat; 2019 Jun; 27(2):101-106. PubMed ID: 31351504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.